These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Tissue factor pathway inhibitor: a potent inhibitor of in-vitro coagulation and in-vivo thrombus formation. Lindahl AK Curr Opin Lipidol; 1994 Dec; 5(6):434-9. PubMed ID: 7712048 [TBL] [Abstract][Full Text] [Related]
3. [The role of tissue factor and its inhibitor in hemostasis]. Naumnik B; Małyszko J; Myśliwiec M Przegl Lek; 1998; 55(2):68-73. PubMed ID: 9695646 [TBL] [Abstract][Full Text] [Related]
4. Loss of heparin-releasable tissue factor pathway inhibitor in patients undergoing PTCA. Anderson S; Cohen AT; Melissari E; Scully MS; Kakkar VV Thromb Haemost; 1995 Feb; 73(2):328-9. PubMed ID: 7792754 [No Abstract] [Full Text] [Related]
5. Tissue factor pathway inhibitor and antithrombin trial results. LaRosa SP; Opal SM Crit Care Clin; 2005 Jul; 21(3):433-48. PubMed ID: 15992666 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of full length and two-domain tissue factor pathway inhibitor in combination with heparin in rabbits. Bregengaard C; Nordfang O; Ostergaard P; Petersen JG; Meyn G; Diness V; Svendsen O; Hedner U Thromb Haemost; 1993 Sep; 70(3):454-7. PubMed ID: 8259548 [TBL] [Abstract][Full Text] [Related]
7. Another point of view on the mechanism of thrombin generation during cardiopulmonary bypass: role of tissue factor pathway inhibitor. Kojima T; Gando S; Kemmotsu O; Mashio H; Goda Y; Kawahigashi H; Watanabe N J Cardiothorac Vasc Anesth; 2001 Feb; 15(1):60-4. PubMed ID: 11254842 [TBL] [Abstract][Full Text] [Related]
8. Tissue factor pathway inhibitor. Camici M; Sagripanti A Minerva Med; 1999; 90(1-2):25-32. PubMed ID: 10388460 [TBL] [Abstract][Full Text] [Related]
9. Tissue factor pathway inhibitor (TFPI). Rucińska M; Gacko M; Skrzydlewski Z Rocz Akad Med Bialymst; 1997; 42 Suppl 1():118-22. PubMed ID: 9337530 [TBL] [Abstract][Full Text] [Related]
10. Reduced tissue factor pathway inhibitor-1 after pharmacological thrombolysis: an epiphenomenon or potential culprit in rethrombosis? Shah PK Circulation; 2002 Jan; 105(3):270-1. PubMed ID: 11804975 [No Abstract] [Full Text] [Related]
12. Molecular weight-dependent influence of heparin on the form of tissue factor pathway inhibitor circulating in plasma. Alban S Semin Thromb Hemost; 2001 Oct; 27(5):503-11. PubMed ID: 11668420 [TBL] [Abstract][Full Text] [Related]
13. Heparin-releasable and platelet pools of tissue factor pathway inhibitor in rabbits. Warn-Cramer BJ; Maki SL; Rapaport SI Thromb Haemost; 1993 Mar; 69(3):221-6. PubMed ID: 8470044 [TBL] [Abstract][Full Text] [Related]
14. Drug interactions involving oral anticoagulants. O'Reilly RA Cardiovasc Clin; 1974; 6(2):23-41. PubMed ID: 4613460 [No Abstract] [Full Text] [Related]
15. Recombinant tissue factor pathway inhibitor enhances the binding of factor Xa to human monocytes. Li A; Chang AC; Peer GT; Wun TC; Taylor FB Thromb Haemost; 2001 May; 85(5):830-6. PubMed ID: 11372676 [TBL] [Abstract][Full Text] [Related]